The interaction between immunogenic macrophages and CD4+ T cells may direct T cell activation and production of Th1/Th17-like cytokines, such as IFNγ and IL-17, resulting in Th1/Th17-mediated anti-GBM GN. The gene discussed is CD4; the disease is glioblastoma.